Bora Pharmaceuticals Co., LTD. (TPE:6472)

Market Cap	64.12B
Revenue (ttm)	21.10B
Net Income (ttm)	3.08B
Shares Out	124.02M
EPS (ttm)	24.04
PE Ratio	15.86
Forward PE	12.57
Dividend	11.67 (2.15%)
Ex-Dividend Date	Jun 20, 2025

Volume	1,463,168
Average Volume	703,339
Open	534.00
Previous Close	542.00
Day's Range	512.00 - 534.00
52-Week Range	468.42 - 795.00
Beta	0.68
RSI	51.79
Earnings Date	Mar 5, 2026

About TPE:6472

Bora Pharmaceuticals Co., LTD. engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally. The company operates through Sales, CDMO, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services and technical services for the development of pharmaceutical products. In addition, it provides Western pharmaceuticals, including central nervous system medications, antibioti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Employees: 36
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6472

Financial Performance

In 2024, TPE:6472's revenue was 19.25 billion, an increase of 35.53% compared to the previous year's 14.20 billion. Earnings were 3.94 billion, an increase of 29.99%.